HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis.

Abstract
Evidence supporting increased nitric oxide (NO) in asthma is substantial, although the cellular and molecular mechanisms leading to increased NO are not known. Here, we provide a clear picture of the events regulating NO synthesis in the human asthmatic airway in vivo. We show that human airway epithelium has abundant expression of NO synthase II (NOSII) due to continuous transcriptional activation of the gene in vivo. Individuals with asthma have higher than normal NO concentrations and increased NOSII mRNA and protein due to transcriptional regulation through activation of Stat1. NOSII mRNA expression decreases in asthmatics receiving inhaled corticosteroid, treatment effective in reducing inflammation in asthmatic airways. In addition to transcriptional mechanisms, post-translational events contribute to increased NO synthesis. Specifically, high output production of NO is fueled by a previously unsuspected increase in the NOS substrate, l -arginine, in airway epithelial cells of asthmatic individuals. Finally, nitration of proteins in airway epithelium provide evidence of functional consequences of increased NO. In conclusion, these studies define multiple mechanisms that function coordinately to support high level NO synthesis in the asthmatic airway. These findings represent a crucial cornerstone for future therapeutic strategies aimed at regulating NO synthesis in asthma.
AuthorsF H Guo, S A Comhair, S Zheng, R A Dweik, N T Eissa, M J Thomassen, W Calhoun, S C Erzurum
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 164 Issue 11 Pg. 5970-80 (Jun 01 2000) ISSN: 0022-1767 [Print] United States
PMID10820280 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA-Binding Proteins
  • Nitrates
  • RNA, Messenger
  • Reactive Oxygen Species
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • Trans-Activators
  • Fluocinolone Acetonide
  • peroxynitric acid
  • Nitric Oxide
  • 3-nitrotyrosine
  • Tyrosine
  • flunisolide
  • Interferon-gamma
  • Arginine
  • NOS2 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Protein-Tyrosine Kinases
  • JAK1 protein, human
  • Janus Kinase 1
Topics
  • Adult
  • Alternative Splicing
  • Arginine (metabolism)
  • Asthma (enzymology, immunology, metabolism)
  • Bronchi (enzymology, metabolism)
  • Bronchoalveolar Lavage Fluid (immunology)
  • DNA-Binding Proteins (metabolism)
  • Epithelial Cells (enzymology, metabolism)
  • Female
  • Fluocinolone Acetonide (analogs & derivatives, pharmacology)
  • Humans
  • Interferon-gamma (metabolism)
  • Janus Kinase 1
  • Male
  • Nitrates (metabolism)
  • Nitric Oxide (biosynthesis)
  • Nitric Oxide Synthase (antagonists & inhibitors, biosynthesis, genetics)
  • Nitric Oxide Synthase Type II
  • Protein Processing, Post-Translational (immunology)
  • Protein-Tyrosine Kinases (metabolism)
  • RNA, Messenger (antagonists & inhibitors)
  • Reactive Oxygen Species (metabolism)
  • STAT1 Transcription Factor
  • Trans-Activators (metabolism)
  • Transcription, Genetic (immunology)
  • Tyrosine (analogs & derivatives, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: